Back
The RMR Group, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
24
RMR
The RMR Group, Inc.
Last Price:
$15.42
Seasonality Move:
-0.05%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.84
Seasonality Move:
40.49%
Sell
24
The RMR Group, Inc. (RMR)
is a Sell
Is The RMR Group, Inc. a Buy, Sell or Hold?
-
The current The RMR Group, Inc. [RMR] share price is $15.25. The Score for RMR is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
RMR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.83. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RMR Stock Price Chart
What is The RMR Group, Inc.'s stock price today?
-
The The RMR Group, Inc. share price today is $15.25The current trend is relatively stagnant and RMR is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
RMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 48.21 | Sell |
| Chaikin Money Flow: | -95085 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.12 - 15.68) | Sell |
| Bollinger Bands (100): | (15.12 - 16.66) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.39 | Buy |
| Relative Strength Index (14 RSI): | 76.07 | Buy |
| Chaikin Money Flow: | 2789125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 58.79) | Buy |
| Bollinger Bands (100): | (20.11 - 45.67) | Buy |
RMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.37 | Sell |
| 20-day SMA: | 15.33 | Sell |
| 50-day SMA: | 15.22 | Buy |
| 200-day SMA: | 16.02 | Sell |
| 8-day EMA: | 15.37 | Sell |
| 20-day EMA: | 15.33 | Sell |
| 50-day EMA: | 15.44 | Sell |
| 200-day EMA: | 16.71 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.94 | Buy |
| 20-day SMA: | 50.39 | Buy |
| 50-day SMA: | 42.93 | Buy |
| 200-day SMA: | 24.04 | Buy |
| 8-day EMA: | 62.02 | Buy |
| 20-day EMA: | 53.73 | Buy |
| 50-day EMA: | 44.48 | Buy |
| 200-day EMA: | 29.61 | Buy |
The RMR Group, Inc. Earnings Growth & RMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.32 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
The RMR Group, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||